Trial Outcomes & Findings for Presyncope (Syncope) Prevention Study (NCT NCT04772755)

NCT ID: NCT04772755

Last Updated: 2023-08-16

Results Overview

Subjects were asked to complete a presyncope symptoms assessment (Modified BDRI: Blood Donations Reactions Inventory) at 20 minutes post vaccination. The number of adolescents with presyncope or syncope as determined by the modified BRDR or witnessed presyncope or syncope.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

338 participants

Primary outcome timeframe

Day 1, 20 minutes post vaccination

Results posted on

2023-08-16

Participant Flow

Participant milestones

Participant milestones
Measure
Usual Care
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Overall Study
STARTED
170
168
Overall Study
COMPLETED
167
165
Overall Study
NOT COMPLETED
3
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Usual Care
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Overall Study
Withdrawal by Subject
1
0
Overall Study
Randomized and subsequently determined to be ineligible
2
3

Baseline Characteristics

Presyncope (Syncope) Prevention Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Usual Care
n=167 Participants
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
n=165 Participants
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Total
n=332 Participants
Total of all reporting groups
Age, Continuous
11.9 years
n=5 Participants
11.8 years
n=7 Participants
11.85 years
n=5 Participants
Sex: Female, Male
Female
86 Participants
n=5 Participants
87 Participants
n=7 Participants
173 Participants
n=5 Participants
Sex: Female, Male
Male
81 Participants
n=5 Participants
78 Participants
n=7 Participants
159 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
11 Participants
n=5 Participants
15 Participants
n=7 Participants
26 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
156 Participants
n=5 Participants
150 Participants
n=7 Participants
306 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
2 Participants
n=7 Participants
2 Participants
n=5 Participants
Race (NIH/OMB)
Asian
10 Participants
n=5 Participants
4 Participants
n=7 Participants
14 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
60 Participants
n=5 Participants
52 Participants
n=7 Participants
112 Participants
n=5 Participants
Race (NIH/OMB)
White
92 Participants
n=5 Participants
87 Participants
n=7 Participants
179 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
3 Participants
n=5 Participants
17 Participants
n=7 Participants
20 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
n=5 Participants
3 Participants
n=7 Participants
5 Participants
n=5 Participants
Region of Enrollment
United States
167 Participants
n=5 Participants
165 Participants
n=7 Participants
332 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 1, 20 minutes post vaccination

Population: Modified Intent-to-treat (mITT) analysis population is defined as those subjects who are enrolled, randomized into the study, and received an intramuscular vaccine.

Subjects were asked to complete a presyncope symptoms assessment (Modified BDRI: Blood Donations Reactions Inventory) at 20 minutes post vaccination. The number of adolescents with presyncope or syncope as determined by the modified BRDR or witnessed presyncope or syncope.

Outcome measures

Outcome measures
Measure
Usual Care
n=167 Participants
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
n=165 Participants
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Number of Adolescents With Presyncope or Syncope After Vaccination in the Intervention and Usual Care Groups.
80 Participants
59 Participants

SECONDARY outcome

Timeframe: Day1: Pre-vaccination (baseline), Post-vaccination (20 minutes)

Population: Modified Intent-to-treat (mITT) analysis population is defined as those subjects who are enrolled, randomized into the study, and received an intramuscular vaccine.

Subjects completed the Youth Momentary Anxiety Checklist pre vaccination and 20 minutes post vaccination. Subjects completed a Likert scale anxiety metric \[The Youth Momentary Anxiety Checklist (YMAC)\], with 12 emotions ranging from 1-4 (1 is best/no anxiety and 4 is worse/highest anxiety) and 1 figure ranging from 1-5 (lowest to highest anxiety) and these 13 scores are added together for analysis. The best/lowest score is a 13 and the highest score is a 53, with the pre-vaccination total score minus the post-vaccination total score as the outcome of interest.

Outcome measures

Outcome measures
Measure
Usual Care
n=163 Participants
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
n=164 Participants
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Categorical Change (Increase, Decrease, no Change) in Pre- and Post- Vaccination State Anxiety.
Increase
28 Participants
28 Participants
Categorical Change (Increase, Decrease, no Change) in Pre- and Post- Vaccination State Anxiety.
Decrease
121 Participants
123 Participants
Categorical Change (Increase, Decrease, no Change) in Pre- and Post- Vaccination State Anxiety.
No Change
14 Participants
13 Participants

SECONDARY outcome

Timeframe: Day1: Pre-vaccination (baseline), Post-vaccination (20 minutes)

Population: Modified Intent-to-treat (mITT) analysis population is defined as those subjects who are enrolled, randomized into the study, and received an intramuscular vaccine.

Subjects were asked to complete the Youth Momentary Anxiety Checklist pre vaccination and 20 minutes post vaccination. Subjects completed a Likert scale anxiety metric \[The Youth Momentary Anxiety Checklist (YMAC)\], with 12 emotions ranging from 1-4 (1 is best/no anxiety and 4 is worse/highest anxiety) and 1 figure ranging from 1-5 (lowest to highest anxiety) and these 13 scores are added together for analysis. The best/lowest score is a 13 and the highest score is a 53, with the pre-vaccination total score minus the post-vaccination total score as the outcome of interest.

Outcome measures

Outcome measures
Measure
Usual Care
n=167 Participants
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
n=165 Participants
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Numeric Change (Mean and Range) in Pre- Minus Post- Vaccination State Anxiety.
5.69 scores on a scale
Interval -13.0 to 37.0
5.23 scores on a scale
Interval -11.0 to 37.0

SECONDARY outcome

Timeframe: Day 1, ≤ 1 minute after vaccination

Population: Modified Intent-to-treat (mITT) analysis population is defined as those subjects who are enrolled, randomized into the study, and received an intramuscular vaccine.

Subjects were asked to complete a pain assessment (The Wong-Baker Faces Pain Scale©) ≤ 1 minute after vaccination. The Wong-Baker Faces Pain Scale is a Likert scale with 6 levels (0,2,4,6,8,10) where 0 is no pain and 10 is the most pain.

Outcome measures

Outcome measures
Measure
Usual Care
n=167 Participants
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
n=165 Participants
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Mean Injection-site Pain Scores on the Wong-Baker Faces Pain Scale© at ≤ 1 Minute Following Vaccination.
3.26 scores on a scale
Interval 0.0 to 10.0
2.51 scores on a scale
Interval 0.0 to 10.0

SECONDARY outcome

Timeframe: Day 1, ≤ 1 minute following vaccination

Population: Modified Intent-to-treat (mITT) analysis population is defined as those subjects who are enrolled, randomized into the study, and received an intramuscular vaccine.

Subjects were asked to complete a pain assessment (The Wong-Baker Faces Pain Scale©) ≤ 1 minute after vaccination. The Wong-Baker Faces Pain Scale is a Likert scale with 6 levels (0,2,4,6,8,10) where 0 is no pain and 10 is the most pain.

Outcome measures

Outcome measures
Measure
Usual Care
n=167 Participants
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
n=165 Participants
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Number of Adolescents Reporting an Injection Site Pain Score ≥ 2, on the Wong-Baker Faces Pain Scale©, ≤ 1 Minute Following Vaccination.
136 Participants
124 Participants

SECONDARY outcome

Timeframe: Day 1, ≤ 1 minute following vaccination

Population: Modified Intent-to-treat (mITT) analysis population is defined as those subjects who are enrolled, randomized into the study, and received an intramuscular vaccine.

Subjects were asked to complete a pain assessment (The Wong-Baker Faces Pain Scale©) ≤ 1 minute after vaccination. The Wong-Baker Faces Pain Scale is a Likert scale with 6 levels (0,2,4,6,8,10) where 0 is no pain and 10 is the most pain.

Outcome measures

Outcome measures
Measure
Usual Care
n=167 Participants
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
n=165 Participants
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Number of Adolescents Reporting an Injection Site Pain Score ≥ 4, on the Wong-Baker Faces Pain Scale©, ≤ 1 Minute Following Vaccination.
77 Participants
53 Participants

SECONDARY outcome

Timeframe: Day 1, (approximately) 10 minutes following vaccination

Population: Modified Intent-to-treat (mITT) analysis population is defined as those subjects who are enrolled, randomized into the study, and received an intramuscular vaccine.

Subjects were asked to complete a pain assessment (The Wong-Baker Faces Pain Scale©) 10 minutes after vaccination. The Wong-Baker Faces Pain Scale is a Likert scale with 6 levels (0,2,4,6,8,10) where 0 is no pain and 10 is the most pain.

Outcome measures

Outcome measures
Measure
Usual Care
n=167 Participants
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
n=165 Participants
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Mean Injection-site Pain Scores on the Wong-Baker Faces Pain Scale© at (Approximately) 10 Minutes Following Vaccination.
1.54 scores on a scale
Interval 0.0 to 10.0
1.09 scores on a scale
Interval 0.0 to 10.0

SECONDARY outcome

Timeframe: Day 1, (approximately) 10 minutes following vaccination

Population: Modified Intent-to-treat (mITT) analysis population is defined as those subjects who are enrolled, randomized into the study, and received an intramuscular vaccine.

Subjects were asked to complete a pain assessment (The Wong-Baker Faces Pain Scale©) 10 minutes after vaccination. The Wong-Baker Faces Pain Scale is a Likert scale with 6 levels (0,2,4,6,8,10) where 0 is no pain and 10 is the most pain.

Outcome measures

Outcome measures
Measure
Usual Care
n=167 Participants
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
n=165 Participants
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Number of Adolescents Reporting an Injection Site Pain Score ≥ 2, on the Wong-Baker Faces Pain Scale©, at (Approximately) 10 Minutes Following Vaccination.
84 Participants
65 Participants

SECONDARY outcome

Timeframe: Day 1, (approximately) 10 minutes following vaccination

Population: Modified Intent-to-treat (mITT) analysis population is defined as those subjects who are enrolled, randomized into the study, and received an intramuscular vaccine.

Subjects were asked to complete a pain assessment (The Wong-Baker Faces Pain Scale©) 10 minutes after vaccination. The Wong-Baker Faces Pain Scale is a Likert scale with 6 levels (0,2,4,6,8,10) where 0 is no pain and 10 is the most pain.

Outcome measures

Outcome measures
Measure
Usual Care
n=167 Participants
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
n=165 Participants
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Number of Adolescents Reporting an Injection Site Pain Score ≥ 4, on the Wong-Baker Faces Pain Scale©, at (Approximately) 10 Minutes Following Vaccination.
30 Participants
19 Participants

SECONDARY outcome

Timeframe: Day 1, approximately 20 minutes post vaccination

Population: Does not apply to the Usual Care arm.

The Buzzy and electronic game acceptability survey consists of 11 items with varying responses.

Outcome measures

Outcome measures
Measure
Usual Care
n=165 Participants
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Like or Dislike
How much do you like having Buzzy on your arm(s) during the shot(s)? · Disliked very much
4 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Like or Dislike
How much do you like having Buzzy on your arm(s) during the shot(s)? · Disliked a little
16 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Like or Dislike
How much do you like having Buzzy on your arm(s) during the shot(s)? · Neither liked nor disliked
28 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Like or Dislike
How much do you like having Buzzy on your arm(s) during the shot(s)? · Liked a little
35 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Like or Dislike
How much do you like having Buzzy on your arm(s) during the shot(s)? · Liked very much
76 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Like or Dislike
How much do you like having Buzzy on your arm(s) during the shot(s)? · Not sure
6 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Like or Dislike
How much do you like playing a game during the shot(s)? · Disliked very much
1 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Like or Dislike
How much do you like playing a game during the shot(s)? · Disliked a little
0 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Like or Dislike
How much do you like playing a game during the shot(s)? · Neither liked nor disliked
19 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Like or Dislike
How much do you like playing a game during the shot(s)? · Liked a little
22 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Like or Dislike
How much do you like playing a game during the shot(s)? · Liked very much
122 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Like or Dislike
How much do you like playing a game during the shot(s)? · Not sure
1 Participants

SECONDARY outcome

Timeframe: Day 1, approximately 20 minutes post vaccination

Population: Does not apply to the Usual Care arm.

The Buzzy and electronic game acceptability survey consists of 11 items with varying responses.

Outcome measures

Outcome measures
Measure
Usual Care
n=165 Participants
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Difficult or Easy
How difficult or easy was holding or having Buzzy held on your arm(s) during the shot(s)? · Very difficult
1 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Difficult or Easy
How difficult or easy was holding or having Buzzy held on your arm(s) during the shot(s)? · Somewhat difficult
8 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Difficult or Easy
How difficult or easy was holding or having Buzzy held on your arm(s) during the shot(s)? · Neither difficult nor easy
15 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Difficult or Easy
How difficult or easy was holding or having Buzzy held on your arm(s) during the shot(s)? · Somewhat easy
23 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Difficult or Easy
How difficult or easy was holding or having Buzzy held on your arm(s) during the shot(s)? · Very easy
111 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Difficult or Easy
How difficult or easy was holding or having Buzzy held on your arm(s) during the shot(s)? · Not sure
7 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Difficult or Easy
How difficult or easy was it to select and play the game? · Very difficult
2 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Difficult or Easy
How difficult or easy was it to select and play the game? · Somewhat difficult
3 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Difficult or Easy
How difficult or easy was it to select and play the game? · Neither difficult nor easy
7 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Difficult or Easy
How difficult or easy was it to select and play the game? · Somewhat easy
21 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Difficult or Easy
How difficult or easy was it to select and play the game? · Very easy
129 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Difficult or Easy
How difficult or easy was it to select and play the game? · Not sure
3 Participants

SECONDARY outcome

Timeframe: Day 1, approximately 20 minutes post vaccination

Population: Does not apply to the Usual Care arm.

The Buzzy and electronic game acceptability survey consists of 11 items with varying responses.

Outcome measures

Outcome measures
Measure
Usual Care
n=165 Participants
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Comfortable or Uncomfortable
How comfortable or uncomfortable was Buzzy on your arm(s) during the shot(s)? · Very uncomfortable
11 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Comfortable or Uncomfortable
How comfortable or uncomfortable was Buzzy on your arm(s) during the shot(s)? · Somewhat uncomfortable
34 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Comfortable or Uncomfortable
How comfortable or uncomfortable was Buzzy on your arm(s) during the shot(s)? · Neither comfortable nor uncomfortable
16 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Comfortable or Uncomfortable
How comfortable or uncomfortable was Buzzy on your arm(s) during the shot(s)? · Somewhat comfortable
47 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Comfortable or Uncomfortable
How comfortable or uncomfortable was Buzzy on your arm(s) during the shot(s)? · Very comfortable
53 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Comfortable or Uncomfortable
How comfortable or uncomfortable was Buzzy on your arm(s) during the shot(s)? · Not sure
4 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Comfortable or Uncomfortable
How comfortable or uncomfortable were you playing a game when receiving shots? · Very uncomfortable
4 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Comfortable or Uncomfortable
How comfortable or uncomfortable were you playing a game when receiving shots? · Somewhat uncomfortable
5 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Comfortable or Uncomfortable
How comfortable or uncomfortable were you playing a game when receiving shots? · Neither comfortable nor uncomfortable
12 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Comfortable or Uncomfortable
How comfortable or uncomfortable were you playing a game when receiving shots? · Somewhat comfortable
37 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Comfortable or Uncomfortable
How comfortable or uncomfortable were you playing a game when receiving shots? · Very comfortable
100 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Comfortable or Uncomfortable
How comfortable or uncomfortable were you playing a game when receiving shots? · Not sure
7 Participants

SECONDARY outcome

Timeframe: Day 1, approximately 20 minutes post vaccination

Population: Does not apply to the Usual Care arm.

The Buzzy and electronic game acceptability survey consists of 11 items with varying responses.

Outcome measures

Outcome measures
Measure
Usual Care
n=165 Participants
Participants received usual care that follows administration of a vaccine and a 20 minute post vaccination observation period.
Buzzy ® and Electronic Game
Buzzy® was applied to the arm receiving vaccination for 30-60 seconds prior to vaccination and removed following vaccination. For the electronic game, participants were instructed to select a game from a prepopulated list of games on a tablet provided by the study team and then play that game for a specified amount of time before, during and after the vaccination administration. Buzzy® and Electronic Game: Buzzy® were applied according to manufacturers directions and an electronic game was played. The participant was observed for 20 minutes post vaccination.
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Yes or no
If you had the choice, would you like to use Buzzy again when receiving shot(s)? · Yes
131 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Yes or no
Did the cold temperature of Buzzy bother you? · No
113 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Yes or no
Did the cold temperature of Buzzy bother you? · Yes
35 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Yes or no
Did the cold temperature of Buzzy bother you? · Not sure
17 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Yes or no
Did the vibration of Buzzy bother you? · No
147 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Yes or no
Did the vibration of Buzzy bother you? · Yes
10 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Yes or no
Did the vibration of Buzzy bother you? · Not sure
8 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Yes or no
If you had the choice, would you like to use Buzzy again when receiving shot(s)? · No
19 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Yes or no
If you had the choice, would you like to use Buzzy again when receiving shot(s)? · Not sure
15 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Yes or no
If you had the choice, would you like to play a game again when receiving shot(s)? · No
18 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Yes or no
If you had the choice, would you like to play a game again when receiving shot(s)? · Yes
134 Participants
Number of Adolescents Reporting Perceptions About Their Vaccination Experience Via an Acceptability Survey - Yes or no
If you had the choice, would you like to play a game again when receiving shot(s)? · Not sure
13 Participants

Adverse Events

Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Buzzy ® and Electronic Game

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Emmanuel B Walter, MD, MPH

Duke University

Phone: 919-620-5346

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place